New class of cancer drugs approved for use in Europe
A “revolutionary” new class of cancer drug that can treat a wide range of tumours has been approved for use in Europe for the first time. Tumour-agnostic drugs ignore the location of where the cancer is growing in the body, providing has a specific genetic abnormality inside. UK doctors testing the drugs has herald the